If you have dosed consistently through a fair trial window and genuinely see nothing, that is a reason to talk to your provider, not a reason to quietly increase the dose
TB-500 (Thymosin Beta-4 Fragment) Cellular-Migration & Tissue-Maintenance Research TB-500 is commonly researched for its interaction with: Cellular-migration and tissue-repair signaling Soft-tissue and connective-tissue pathways Recovery-focused regenerative mechanisms Mobility- and flexibility-related pathways Physiological-resilience and tissue-maintenance research Research involving TB-500 commonly investigates its potential interaction with connective-tissue pathways, tissue-remodeling pathways, angiogenesis-related signaling, and recovery-focused physiological mechanisms
Dietary ConsiderationsDairy/ Milk Free Gluten Free Soy Free Non-GMO Amount Per Serving2x Cardio Prime Niacin (as Cuprous Niacin) 0.83 mg Copper (as Cuprous Niacin) 0.2 mg NAD3 Proprietary Blend (Wasabi extract (Wasabia japonica), Theacrine, Cuprous Niacin) 312 mg Lactotripeptides [Isoleucyl-prolyl-proline (IPP) and Valyl-prolyl-proline (VPP)][as VasoDrive-AP] 508 mg Citrus Bergamot Extract (Fruit) 250 mg CurcuPrime Tetrahydrocurcumin 200 mg NSK-SD Nattokinase (2,000 FU) (soy) 100 mg 2x Green Tea Green Tea Extract (Leaf) 630 mg 1x CoQ10 Coenzyme Q10 (from MicroActive Q10-cyclodextrin complex and CoQ10) 120 mg Other Ingredients: Microcrystalline Cellulose, Magnesium Stearate (Vegetable), Silica, Vegetable Capsule (Hypromellose), Cellulose, Vegetarian Magnesium Stearate, Vegetable Capsule (Hypromellose), Rice Powder, Microcrystalline Cellulose, Magnesium Stearate, Silicon Dioxide Dosage: Take 1 full sachet pack daily, at bedtime or with evening meal, or as recommended by your healthcare professional If pregnant, nursing, or taking prescription drugs, consult your healthcare professional prior to use
Symptoms can be subtle, but B12 shots can completely change how you feel on a day to day basis
Results Cell Viability Assay Cell viability tests were performed on HaCaT keratinocytes cells with the treatment of GHK, CuCl 2 and Cu(OAc) 2 for 24, 48 and 72 h
